Integer Holdings Corp (NYSE:ITGR) SVP Anthony W. Borowicz sold 2,500 shares of the firm’s stock in a transaction on Thursday, March 14th. The stock was sold at an average price of $85.92, for a total value of $214,800.00. Following the completion of the transaction, the senior vice president now owns 18,124 shares in the company, valued at approximately $1,557,214.08. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.
NYSE:ITGR traded down $0.19 during trading hours on Thursday, hitting $85.63. The company’s stock had a trading volume of 154,611 shares, compared to its average volume of 177,266. The firm has a market capitalization of $2.79 billion, a PE ratio of 22.53 and a beta of 1.01. The company has a quick ratio of 1.37, a current ratio of 2.53 and a debt-to-equity ratio of 0.84. Integer Holdings Corp has a twelve month low of $54.20 and a twelve month high of $92.61.
Integer (NYSE:ITGR) last announced its quarterly earnings results on Thursday, February 21st. The medical equipment provider reported $1.04 EPS for the quarter, beating the Zacks’ consensus estimate of $0.92 by $0.12. Integer had a return on equity of 12.56% and a net margin of 12.88%. The firm had revenue of $303.00 million for the quarter, compared to analyst estimates of $301.25 million. During the same period last year, the firm posted $0.96 earnings per share. The business’s revenue for the quarter was up .2% on a year-over-year basis. On average, analysts anticipate that Integer Holdings Corp will post 4.2 EPS for the current fiscal year.
ITGR has been the topic of several research analyst reports. TheStreet raised Integer from a “c+” rating to a “b-” rating in a research note on Monday, December 17th. Royal Bank of Canada raised their price objective on Integer from $84.00 to $92.00 and gave the company a “sector perform” rating in a research note on Monday, February 25th. Finally, Zacks Investment Research raised Integer from a “hold” rating to a “strong-buy” rating and set a $101.00 price objective on the stock in a research note on Tuesday, February 26th. One analyst has rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus price target of $89.40.
Integer Company Profile
Integer Holdings Corporation operates as a medical device outsource manufacturer worldwide. It operates in two segments, Medical and Non-Medical. The company offers products for vascular, cardiac surgery, and structural heart diseases; peripheral vascular, neurovascular, urology, and oncology products; and electrophysiology, infusion therapy, and hemodialysis products.
Further Reading: Stock Selection – What is cash flow?
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.